Article
Simvastatin treatment ameliorates autoimmune disease associated with accelerated atherosclerosis in a murine lupus model.
Journal of immunology (Baltimore, Md. : 1950) - 1 Sept 2006
Aprahamian Tamar, Bonegio Ramon, Rizzo Jennifer, Perlman Harris, Lefer David J, Rifkin Ian R, Walsh Kenneth
Abstract excerpt
Patients with systemic lupus erythematosus develop accelerated atherosclerosis independent of traditional risk factors. The 3-hydroxy-3-methyl-glutaryl coenzyme A (HMG-CoA) reductase inhibitors are widely prescribed for hyperlipidemia, but they also exhibit anti-inflammatory actions that appear to be independent of their suppressive actions on plasma cholesterol levels. In this study, we analyzed the effect of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
